Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

17 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-31

Study Completion Date

2017-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Octanoic Acid for Essential Tremor

NCT01468948

Essential Tremor

COMPLETED PHASE1

Double-Blind, Placebo Controlled Pilot Study of Octanoic Acid in Essential Tremor

NCT00848172

Essential Tremor

COMPLETED PHASE1/PHASE2

1-Octanol to Treat Essential Tremor

NCT00001986

Essential Tremor

COMPLETED PHASE1

Dextromethorphan to Treat Patients With Voice Spasms

NCT00055549

Voice Disorders

COMPLETED PHASE1

Safety, Efficacy, and Tolerability of NBI-827104 for the Treatment of Essential Tremor

NCT04880616

Essential Tremor

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

* Essential tremor of the voice produces regular shaking and hoarseness in the voice, making it difficult speech difficult to understand
* Several previous studies have found that octanoic acid and octanol, which are related to alcohol, can improve tremor in some people without producing many side effects and without producing intoxication
* Researchers are interested in determining whether octanoic acid can improve tremor that affects the voice

Objectives:

* To determine the effects of octanoic voice using voice recordings and listener ratings of voice
* To determine the effects of octanoic acid on level of voice disability experienced by people with essential voice tremor

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Essential Voice Tremor Vocal Tremor Voice Tremor Essential Tremor of Voice

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inactive capsule

Participants will receive a pill/capsule with an inactive ingredient during the placebo arm of this study.

Group Type PLACEBO_COMPARATOR

Inactive capsule

Intervention Type DRUG

Octanoic acid

Participants will receive a pill/capsule with octanoic acid (amount determined by the participant's weight) during the experimental arm of this study.

Group Type EXPERIMENTAL

Octanoic acid

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Octanoic acid

Intervention Type DRUG

Inactive capsule

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Caprylic acid Placebo

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants have a diagnosis of essential voice tremor and show signs of tremor during the endoscopy examination (when pictures of the voice box are obtained)during screening appointment
* Participants show measurable voice tremor from recordings of the voice during screening appointment

Exclusion Criteria

* Participants have a diagnosis or show signs of Parkinson's Disease or another non-essential tremor movement disorder
* Participants have a diagnosis or show signs of spasmodic dysphonia (a different neurological voice disorder)
* Participants have a diagnosis of a severe, non-stable medical condition, such as kidney or liver failure, severe heart disease, severe lung disease, severe metabolic disease, uncontrolled hyperthyroidism, or other life-threatening disease such as active cancer
* Participants have a diagnosis of diabetes mellitus
* Participants are unable to suspend/stop a medication that they are currently taking for tremor or voice disorder for 12 weeks to complete this study
* Participants have a dependence on alcohol or allergy to alcohol
* Participants are pregnant or lactating
* Participants have an allergy to soy
* Participants have Irritable Bowel Syndrome

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No